Results 321 to 330 of about 8,570,567 (357)
Sub‐monolayer titania grafted onto mesoporous silica enables solvent‐free photocatalytic upgrading of furfural and cyclopentanone into jet fuel precursors. Advanced spectroscopic methods reveal tunable surface speciation, acidity, and bandgaps, enhancing catalytic efficiency.
Mark A. Isaacs +12 more
wiley +1 more source
Correlation between the extracellular volume fraction and hemodynamic parameters in light-chain cardiac amyloidosis patients. [PDF]
Lu Y +5 more
europepmc +1 more source
An additive and initiator‐free photoresin based on a prepolymer decorated with photoreactive step‐growth units as crosslinkers allows for the fabrication of 3D microstructures with strongly disparate mechanical properties ranging from stiff to soft. Abstract Manufacturing three‐dimensional (3D) microstructures with multi‐material properties via two ...
Tugce Nur Eren +7 more
wiley +1 more source
Plasma Neurofilament Light Chain Is Associated with Cognitive Functions but Not Patient-Reported Outcomes in Multiple Sclerosis. [PDF]
Nicolella V +16 more
europepmc +1 more source
Cu‐based catalysts as a cornerstone in advancing sustainable energy technologies are fully reviewed in this manuscript, highlighting their potential in photo‐ and electrocatalysis. It includes metallic copper, copper oxides, copper sulfides, copper halide perovskites, copper‐based metal–organic frameworks (MOFs), and covalent organic frameworks (COFs),
Jéssica C. de Almeida +16 more
wiley +1 more source
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Sclerosis. [PDF]
Taluntiene V +4 more
europepmc +1 more source
Beyond NT-proBNP and troponin: How machine learning redefines light-chain cardiac amyloidosis risk assessment. [PDF]
Wu D +6 more
europepmc +1 more source
An early marker of monoclonal light chain protein In bladder cancer
Amr Ibrahim +4 more
openalex +1 more source
Predictive value of free light chain burden in patients with AL amyloidosis treated with bortezomib-based regimens. [PDF]
Saunders B +7 more
europepmc +1 more source

